NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

  News | News By Subject | News by Disease News By Date | Search News
   

Gamma Pharmaceuticals and 360 Distribution Reach Agreement for Retail Market Coverage With First Year Market Value of Up to $750,000
6/23/2009

LAS VEGAS, NV--(Marketwire - June 23, 2009) - Gamma Pharmaceuticals Inc. (OTCBB: GMPM) announces an agreement with 360 Distribution, a major distributor in Texas. Gamma estimates a retail market value of approximately $750K in the first year. Gamma has established a very effective network of distributor resources and direct to retail systems throughout key markets in USA and China. 360 Distributors is another important link in Gamma's expanding distribution universe. Gamma's CEO, Peter Cunningham, commented, "We are pleased to team up with a high quality distributor like 360 Distributors that can provide direct distribution support for Gamma's retail promotions and market penetration. Retail chains are supportive of Gamma's aggressive promotion program for the territory and are taking product immediately."

Mr. Cunningham continued, "Major retailers' acceptance of Gamma's brands and promotion programs make the distributors confident to push the brands very hard in the marketplace."

Gamma Pharmaceuticals Inc. is a marketing and product formulation company. We have created, registered, and branded innovative product lines including Nutritional Supplements, Personal Care Products and Over-The-Counter (OTC) pharmaceuticals. At present Gamma manufactures in North America, and distributes in the United States and China. Gamma's products utilize proprietary "Gel Delivery Technology®," to create innovative gel product forms; that give consumers a more pleasant experience. Gel Delivery Technology® characteristics include rapid absorption, convenience and taste great. Market categories Gamma targets are growing as rapidly as 60% per year.

Gamma master brands include: Brilliant Choice®, range of children's vitamins, nutritional supplements and immune boosters, Savvy® a range of adult vitamins, nutritional supplements and immune boosters. Youth targeted products are sold as Jugular® Energy - "Go for the Jugular™." In addition, Gamma has developed formulas and strategies for Metabolic Syndrome and Diabetes Type II, Stress reduction, Cognition, Well being, Menopause Symptoms, and Personal Care Products. Gamma also develops and manufactures house brands for major retailers. At this time Gamma is holding licenses for 9 SKUs in China.

Forward-Looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.


Contact:
Gamma Pharmaceuticals Inc.
Joe Cunningham
jcunningham@gammapharma.com

Office: (702) 989 5262
Direct: (651) 204 2048



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES